Not finding it? Sign in to also search OpenAlex live.
-
Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC2023 BMC Medical Research Methodology erratum Medicine Lung Cancer Treatments and Mutations Open access
Rawa Kamaran Ismail, Franz M.N.H. Schramel, Maaike van Dartel, Anna M.G. Pasmooij, Christine M. Cramer‐van der Welle, Doranne L. Hilarius, +3 more
0citations -
Corrigendum to ‘Final Analysis Results and Patient-Reported Outcomes From DESTINY-Lung02—A Dose-Blinded, Randomized, Phase 2 Study of Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic NSCLC’ [Journal of Thoracic Oncology Volume 20 Issue 12 (2025) 1814-1828]
Pasi Antero Janne, Yasushi Goto, Toshio Kubo, Kiichiro Ninomiya, Sang-We Kim, David Planchard, +15 more
0citations
3 results